# The Novavax Covid-19 Vaccine Candidate May Outshine Major Companies

- Link: https://www.widthness.com/the-novavax-covid-19-vaccine-candidate-may-outshine-major-companies/
- Published: 2020-11-08T09:45:54-06:00
- Author: Curated by Theresa Wysocki

Image: Recombinant Protein Nanoparticles – Novavax. Article by Hannah C. In 2019, Novavax nearly closed down after bad management and failed vaccine trials. Today, they are one of the leading companies recognized in developing a coronavirus vaccine. In September, their coronavirus vaccine candidate, NVX-CoV2373, began late-stage clinical trials in the United Kingdom. The United States and Mexico will also […] Click here to view original web page at www.sciencetimes.com